© 2019 by ATXA Therapeutics Limited.

Dublin, Ireland

Home  |  About Us  |  News  |  Contact Us

Follow us on:

  • LinkedIn Social Icon
  • Facebook Social Icon
  • Twitter Social Icon

NEWS & INSIGHTS

March 8, 2018

DUBLIN, IRELAND – March 8, 2018 – ATXA Therapeutics Limited, an early-stage Irish biopharmaceutical company focused on clinical development of novel small molecule drugs to treat Pulmonary Arterial Hypertension (PAH), is pleased to announce that the United States Food...

February 2, 2018

DUBLIN, IRELAND – February 2, 2018 – ATXA Therapeutics Limited, an early-stage Irish biopharmaceutical company focused on clinical development of novel small molecule drugs to treat Pulmonary Arterial Hypertension (PAH), announced today that its Founder and Chief Scien...

Please reload

Recent Posts

September 30, 2019

Please reload

Archive
Please reload

Search By Tags
Please reload